FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,964,000 | -81.5% | 50,000 | -73.0% | 0.87% | -80.4% |
| Q2 2021 | $16,056,000 | +5.3% | 185,000 | 0.0% | 4.41% | +23.1% |
| Q1 2021 | $15,253,000 | +1.7% | 185,000 | +12.1% | 3.58% | +7.2% |
| Q4 2020 | $15,003,000 | +87.7% | 165,000 | -17.5% | 3.34% | +44.7% |
| Q3 2020 | $7,994,000 | +86.4% | 200,000 | +60.0% | 2.31% | +104.1% |
| Q2 2020 | $4,289,000 | -14.2% | 125,000 | -44.4% | 1.13% | -14.6% |
| Q1 2020 | $4,997,000 | -7.2% | 225,000 | -18.2% | 1.32% | +29.3% |
| Q4 2019 | $5,382,000 | -1.0% | 275,000 | -21.4% | 1.02% | -26.0% |
| Q3 2019 | $5,436,000 | +344.8% | 350,000 | +366.7% | 1.38% | +432.7% |
| Q3 2018 | $1,222,000 | +156.7% | 75,000 | -15.9% | 0.26% | +21.5% |
| Q3 2015 | $476,000 | – | 89,231 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |